CD8A and hepatocellular carcinoma: Clinical observation demonstrated that when residual antigen-specific CD8+ T cells were persistently activated but unable to control HBV replication, they might contribute to sustain liver inflammations predisposing patients to HCC development (11, 13, 15, 16, 19).